Chimerism after Liver Transplantation for Type IV Glycogen Storage Disease and Type 1 Gaucher's Disease

New England Journal of Medicine

Volumn 328, Issue 11, 1993, Pages 745-749

  Starzl, Thomas E ^a   Demetris, Anthony J ^b   Trucco, Massimo ^b   Ricordi, Camillo ^a   Ildstad, Suzanne ^a   Terasaki, Paul I ^c   Murase, Noriko ^a   Kendall, Ross S ^d   Kocova, Mirjana ^b   Rudert, William A ^b   Zeevi, Adriana ^a,b   Van Thiel, David ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Mary Bridge Children's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOPECTIN; GLUCOSYLCERAMIDE; HLA DR ANTIGEN;

ADULT; ANTIBODY SPECIFICITY; ARTICLE; CASE REPORT; CHIMERA; ENZYME METABOLISM; GAUCHER DISEASE; GLYCOGEN STORAGE DISEASE TYPE 4; HISTOPATHOLOGY; HLA SYSTEM; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL;

ADULT; AMYLOPECTIN; CELL MOVEMENT; CHIMERA; DNA; GAUCHER DISEASE; GLUCOSYLCERAMIDES; GLYCOGEN STORAGE DISEASE TYPE IV; HLA ANTIGENS; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; LIVER; LIVER TRANSPLANTATION; LYMPH NODES; MALE; MYOCARDIUM; SKIN; SUPPORT, U.S. GOV'T, P.H.S.; TRANSPLANTATION, HOMOLOGOUS;

EID: 0027516542     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199303183281101     Document Type: Article

References (29)

1. Brown BI, Brown DH Lack of an α-1,4-glucan:α-1,4-glucan 6-glycosyl transferase in a case of Type IV glycogenosis. Proc Natl Acad Sci U S A 1966; 56:725-729
2. Selby R, Starzl TE, Yunis E, Brown BI, Kendall RS, Tzakis A Liver transplantation for Type IV glycogen storage disease. N Engl J Med 1991; 324:39-42
3. Howell RR Continuing lessons from glycogen storage diseases. N Engl J Med 1991; 324:55-56
4. Brady RO, Kanfer JN, Bradley RM, Shapiro D Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease. J Clin Invest 1966; 45:1112-1115
5. Hsia S, Tong JY, Parris GL, et al. 1992 Molecular compatibility and renal graft survival: the HLA DRB1 genotyping. Transplantation (in press).
6. Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M Cell migration, chimerism, and graft acceptance. Lancet 1992; 339:1579-1582
7. Porter KA. Pathology of the orthotopic homograft and heterograft. In: Starzl TE, ed. Experience in hepatic transplantation. Philadelphia: W.B. Saunders, 1969:464-5.
8. Gouw AS, Houthoff HJ, Huitema S, Beelen JM, Gips CH, Poppema S Expression of major histocompatibility complex antigens and replacement of donor cells by recipient ones in human liver grafts. Transplantation 1987; 43:291-296
9. Starzl TE. Cell migration and chimerism: a unifying concept in transplantation: with particular reference to HLA matching and tolerance induction. Transplant Proc (in press).
10. Starzl TE, Demetris AJ, Trucco M, Systemic chimerism in human female recipients of male livers. Lancet 1992; 340:876-877
11. Calne RY, Sells RA, Pena JR, Induction of immunological tolerance by porcine liver allografts. Nature 1969; 223:472-476
12. Steinman RM, Cohn ZA Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 1973; 137:1142-1162
13. Steinman RM The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991; 9:271-296
14. Lechler RI, Batchelor JR Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med 1982; 155:31-41
15. Demetris AJ, Murase N, Starzl TE Donor dendritic cells after liver and heart allotransplantation under short-term immunosuppression. Lancet 1992; 339:1610-1610
16. Ricordi C, Ildstad ST, Demetris AJ, Abou El-Ezz AY, Murase N, Starzl TE Donor dendritic cells repopulation in recipients after rat-to-mouse bone-marrow transplantation. Lancet 1992; 339:1610-1611
17. Ramsey G, Nusbacher J, Starzl TE, Lindsay GD Isohemagglutinins of graft origin after ABO-unmatched liver transplantation. N Engl J Med 1984; 311:1167-1170
18. Burdick JF, Vogelsang GB, Smith WJ, Severe graft-versus-host disease in a liver-transplant recipient. N Engl J Med 1988; 318:689-691
19. Comenzo RL, Malachowski ME, Rohrer RJ, Freeman RB, Rabson A, Berkman EM Anomalous ABO phenotype in a child after an ABO-incompatible liver transplantation. N Engl J Med 1992; 326:867-870
20. Roberts JP, Ascher NL, Lake J, Graft vs. host disease after liver transplantation in humans: a report of four cases. Hepatology 1991; 14:274-281
21. Ferry GD, Whisennand HH, Finegold MJ, Alpert E, Glombicki A Liver transplantation for cholesteryl ester storage disease. J Pediatr Gastroenterol Nutr 1991; 12:376-378
22. Daloze P, Delvin EE, Glorieux FH, Corman JL, Bettez P, Toussi T Replacement therapy for inherited enzyme deficiency: liver orthotopic transplantation in Niemann-Pick disease type A. Am J Med Genet 1977; 1:229-239
23. DuCerf C, Bancel B, Caillon P, Orthotopic liver transplantation for type 1 Gaucher's disease. Transplantation 1992; 53:1141-1143
24. Parkman R The application of bone marrow transplantation to the treatment of genetic diseases. Science 1986; 232:1373-1378
25. Neufeld EF Lessons from genetic disorders of lysosomes. Harvey Lect 1981; 75:41-60
26. Starzl TE, Bilheimer DW, Bahnson HT, Heart-liver transplantation in a patient with familial hypercholesterolaemia. Lancet 1984; 1:1382-1383
27. Bilheimer DW, Goldstein JL, Grundy SM, Starzl TE, Brown MS Liver transplantation provides low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia. N Engl J Med 1984; 311:1658-1664
28. Jones EA, Summerfield SA. Kupffer cells. In: Arias IM, Popper H, Schachter D, Shafritz DA, eds. The liver: biology and pathobiology. New York: Raven Press, 1982:507-23.
29. Desnick RJ, Simmons RL, Allen KY, Correction of enzymatic deficiencies by renal transplantation: Fabry's disease. Surgery 1972; 72:203-211